FDA Enforcement Class II Terminated

Mobius3D Product Usage: Mobius3D software is used for quality assurance and treatment plan verification in radiation therapy. It calculates radiation dose three-dimensionally in a representation of a patient or a phantom. The calculation is based on read-in treatment plans that are initially calculated by a treatment planning system, and may additionally be based on external measurements of radiation fields from other sources such as linac delivery log data. Mobius3D is not a treatment planning system. It is only to be used by trained radiation oncology personnel as a quality assurance tool.

Recall: Z-2100-2017 · Reported May 24, 2017

Enforcement

Recall Number
Z-2100-2017
Event ID
77177
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Mobius Medical Systems, LP
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
May 24, 2017
Initiation Date
February 23, 2015
Classification Date
May 16, 2017
Termination Date
July 10, 2017
Address
4615 Southwest Fwy Ste 330, Houston, TX, 77027-7106, United States

Description

Mobius3D Product Usage: Mobius3D software is used for quality assurance and treatment plan verification in radiation therapy. It calculates radiation dose three-dimensionally in a representation of a patient or a phantom. The calculation is based on read-in treatment plans that are initially calculated by a treatment planning system, and may additionally be based on external measurements of radiation fields from other sources such as linac delivery log data. Mobius3D is not a treatment planning system. It is only to be used by trained radiation oncology personnel as a quality assurance tool.

Reason

Mobius3D version 1.5.0 contained a defect in software code which affects users who perform beam customization, and may lead to a discrepancy in dose calculation between this version of Mobius3D (1.5.0) and the prior version (1.4.2), where none should have been expected.

Code Info

Version 1.5.0 and 1.5.2 of the Mobius3D software is affected.

Distribution

Worldwide distribution - US Nationwide and the countries of Sweden, Canada, Netherlands, Denmark, Spain, Switzerland, Australia, Austria, Israel, United Kingdom, France

Quantity

270